Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis

Multiple Sclerosis

Volumn 14, Issue 6, 2008, Pages 857-859

  Sena, Armando ^a,b   Pedrosa, R ^b   Ferret Sena, V ^c   Cascais, M J ^a   Roque, R ^b   Araujo C ^b   Couderc, R ^d  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DOS CAPUCHOS   (Portugal)

^c Departmento de Fisiologia   (Portugal)

^d ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Ferritin; Interferon beta; Iron metabolism; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; BILIRUBIN; FERRITIN; HEMOGLOBIN; INTERFERON BETA SERINE; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON METABOLISM; MALE; MULTIPLE SCLEROSIS; PROTEIN ANALYSIS; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ADULT; BILIRUBIN; DRUG MONITORING; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEX CHARACTERISTICS;

EID: 48349084164     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508089687     Document Type: Article

References (14)

1. Le Vine, SM, Lynch, SG, Ou, C-N, Wulser, MJ, Tam, E, Boo, N. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999; 821: 511-515.
2. Sfagos, C, Makis, AC, Chaidos, A, Hatsimichael, EC, Dabmaga, A, Kosma, K, et al. Serum ferritin, transferrin and soluble tranferrin receptor levels in multiple sclerosis patients. Mult Scler 2005; 11: 272-275.
3. Exley, C, Mamutse, G, Korchazhkina, O, Pye, E, Strekopytov, S, Polwart, A, et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis. Mult Scler 2006; 12: 533-540.
4. Otterbein, LE, Soares, MP, Yamashita, K, Bach, FH. Heme, oxygenase-1: undeashing the protective properties of heme. Trends Immunol 2003; 24: 449-455.
5. Novotny, L, Vitek, L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228: 568-571.
6. Williams, MJA, Poulton, R, Williams, S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002; 165: 179-184.
7. Wolff, B, Volzke, H, Ludemann, J, Robinson, D, Vogelgesang, D, Staudt, A, et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 2004; 35: 453-457.
8. Torti, FM, Torti, SV. Regulation of ferritin genes and protein. Blood 2002; 99: 3505-3516.
9. Mehindate, K, Sahlas, DJ, Frankel, D, Mawal, Y, Liberman, A, Corcos, J, et al. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 2001; 77: 1386-1395.
10. Chakrabarty, A, Emerson, MR, Le Vine, SM. Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult Scler 2003; 9: 372-381.
11. Ren, H, Leib, SL, Ferniero, DM, Tauber, MG, Chisten, S. Induction of haeme oxygenase-1 causes cortical non-haeme iron increase in experimental pneumococcal meningitis: evidence that concomitant ferritin up-regulation prevents iron-induced oxidative damage. J Neurochem 2007; 100: 532-544.
12. Le Vine, SM, Maiti, S, Emerson, MR, Pedchenko, TV. Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice. Dev Neurosci 2002; 24: 177-183.
13. Mitchell, KM, Dotson, AL, Cool, KM, Chakrabarty, A, Benedict, SH, LeVine, SM. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler 2007; 13: 1118-1126.
14. Hofer, H, Osterreicher, C, Jessner, W, Penz, M, Steindl-Munda, P, Wrba, F, et al. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol 2004: 40; 1018-1022.